Key result
Neoadjuvant radiation successfully reduced the size of a borderline resectable pulmonary artery intimal sarcoma from 3.2 x 2.0 cm to 2.2 x 1.2 cm, enabling complete surgical resection with no recurrence at 4 months.
Why the study?
Intimal sarcoma of the pulmonary artery is primarily treated surgically, but no prior reports had documented the utility of neoadjuvant radiotherapy to improve resectability.
Case Report (n=1)
No
Neoadjuvant radiotherapy may be a viable strategy to improve resectability in cases of borderline resectable intimal sarcoma of the pulmonary artery.
Answers are grounded in this paper and cite their sources.
May support neoadjuvant radiotherapy for unresectable pulmonary artery intimal sarcoma; leaves open need for prospective trials.
Intimal sarcoma (IS) is a rare malignancy arising in the great vessels or heart, most commonly in the pulmonary artery, primarily treated with surgical intervention. We report a case of IS of the pulmonary artery diagnosed after an endarterectomy to remove a suspected pulmonary embolism. The tumor could not be entirely resected and showed interval growth at post-operative follow up. Neoadjuvant radiotherapy was then delivered to improve resectability. Imaging confirmed decreased tumor size, and a surgical resection with pulmonary artery reconstruction and right upper lobectomy was then successfully performed. Adjuvant gemcitabine and docetaxel was later initiated. Four months post-operatively, the patient is alive without disease recurrence. While prior reports in the literature document use of adjuvant chemotherapy and radiotherapy for treatment of IS of the pulmonary artery, no prior experience has documented utility of neoadjuvant radiotherapy for improvement of resectability. Our experience suggests that neoadjuvant radiation should be considered to improve resectability in cases of borderline resectable IS of the pulmonary artery.
No takes yet. Share an insight, caveat, or question.
Allen et al. (2021) conducted a case report in Intimal sarcoma of the pulmonary artery (n=1). Neoadjuvant radiation was evaluated on Tumor size and resectability. Neoadjuvant radiation successfully reduced the size of a borderline resectable pulmonary artery intimal sarcoma from 3.2 x 2.0 cm to 2.2 x 1.2 cm, enabling complete surgical resection with no recurrence at 4 months.
Synapse has enriched 10 related papers. Consider them for comparative context: